These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1045 related items for PubMed ID: 19627999

  • 1. Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.
    Uslaner JM, Parmentier-Batteur S, Flick RB, Surles NO, Lam JS, McNaughton CH, Jacobson MA, Hutson PH.
    Neuropharmacology; 2009; 57(5-6):531-8. PubMed ID: 19627999
    [Abstract] [Full Text] [Related]

  • 2. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
    Sarantis K, Matsokis N, Angelatou F.
    Neuroscience; 2009 Nov 10; 163(4):1135-45. PubMed ID: 19647050
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration.
    Parmentier-Batteur S, O'Brien JA, Doran S, Nguyen SJ, Flick RB, Uslaner JM, Chen H, Finger EN, Williams TM, Jacobson MA, Hutson PH.
    Neuropharmacology; 2012 Mar 10; 62(3):1453-60. PubMed ID: 21112344
    [Abstract] [Full Text] [Related]

  • 4. Food restriction increases NMDA receptor-mediated calcium-calmodulin kinase II and NMDA receptor/extracellular signal-regulated kinase 1/2-mediated cyclic amp response element-binding protein phosphorylation in nucleus accumbens upon D-1 dopamine receptor stimulation in rats.
    Haberny SL, Carr KD.
    Neuroscience; 2005 Mar 10; 132(4):1035-43. PubMed ID: 15857708
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Brain-derived neurotrophic factor acutely enhances tyrosine phosphorylation of the AMPA receptor subunit GluR1 via NMDA receptor-dependent mechanisms.
    Wu K, Len GW, McAuliffe G, Ma C, Tai JP, Xu F, Black IB.
    Brain Res Mol Brain Res; 2004 Nov 04; 130(1-2):178-86. PubMed ID: 15519688
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
    Pandis C, Sotiriou E, Kouvaras E, Asprodini E, Papatheodoropoulos C, Angelatou F.
    Neuroscience; 2006 Jun 19; 140(1):163-75. PubMed ID: 16542781
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine.
    Clifton NE, Morisot N, Girardon S, Millan MJ, Loiseau F.
    Psychopharmacology (Berl); 2013 Feb 19; 225(3):579-94. PubMed ID: 22983144
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities.
    Liu F, Grauer S, Kelley C, Navarra R, Graf R, Zhang G, Atkinson PJ, Popiolek M, Wantuch C, Khawaja X, Smith D, Olsen M, Kouranova E, Lai M, Pruthi F, Pulicicchio C, Day M, Gilbert A, Pausch MH, Brandon NJ, Beyer CE, Comery TA, Logue S, Rosenzweig-Lipson S, Marquis KL.
    J Pharmacol Exp Ther; 2008 Dec 19; 327(3):827-39. PubMed ID: 18753411
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice.
    Horio M, Fujita Y, Hashimoto K.
    Fundam Clin Pharmacol; 2013 Oct 19; 27(5):483-8. PubMed ID: 22594375
    [Abstract] [Full Text] [Related]

  • 14. Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation.
    Yamamoto Y, Shioda N, Han F, Moriguchi S, Nakajima A, Yokosuka A, Mimaki Y, Sashida Y, Yamakuni T, Ohizumi Y, Fukunaga K.
    Brain Res; 2009 Oct 27; 1295():218-29. PubMed ID: 19646972
    [Abstract] [Full Text] [Related]

  • 15. mGluR5 positive allosteric modulation prevents MK-801 induced increases in extracellular glutamate in the rat medial prefrontal cortex.
    LaCrosse AL, May CE, Griffin WC, Olive MF.
    Neuroscience; 2024 Sep 13; 555():83-91. PubMed ID: 39019391
    [Abstract] [Full Text] [Related]

  • 16. Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex.
    Lecourtier L, Homayoun H, Tamagnan G, Moghaddam B.
    Biol Psychiatry; 2007 Oct 01; 62(7):739-46. PubMed ID: 17511968
    [Abstract] [Full Text] [Related]

  • 17. 4'-Demethylnobiletin, a bioactive metabolite of nobiletin enhancing PKA/ERK/CREB signaling, rescues learning impairment associated with NMDA receptor antagonism via stimulation of the ERK cascade.
    Al Rahim M, Nakajima A, Saigusa D, Tetsu N, Maruyama Y, Shibuya M, Yamakoshi H, Tomioka Y, Iwabuchi Y, Ohizumi Y, Yamakuni T.
    Biochemistry; 2009 Aug 18; 48(32):7713-21. PubMed ID: 19601643
    [Abstract] [Full Text] [Related]

  • 18. MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia?
    Vardigan JD, Huszar SL, McNaughton CH, Hutson PH, Uslaner JM.
    Pharmacol Biochem Behav; 2010 Apr 18; 95(2):223-9. PubMed ID: 20122952
    [Abstract] [Full Text] [Related]

  • 19. Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs.
    Fumagalli F, Frasca A, Racagni G, Riva MA.
    Mol Pharmacol; 2008 May 18; 73(5):1484-90. PubMed ID: 18250147
    [Abstract] [Full Text] [Related]

  • 20. CaM kinase II and protein kinase C activations mediate enhancement of long-term potentiation by nefiracetam in the rat hippocampal CA1 region.
    Moriguchi S, Shioda N, Han F, Narahashi T, Fukunaga K.
    J Neurochem; 2008 Aug 18; 106(3):1092-103. PubMed ID: 18445137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.